Cambodia Becomes "Illegal Drug Dump"

13 October 1996

Cambodian Ministry of Health officials have said the country has become a dumping ground for illegal pharmaceuticals, with more than half of the $180 million annually spent on medicines being used to purchase these products.

The Secretary of State for Health, Dy Narongrith, said that drugs, which were faulty or past their expiry date, came from neighboring countries to be sold in unlicensed pharmacies, which outnumber legal shops two-to-one, according to Reuters. There are more than 560 illegal pharmacies in the capital Phnom Penh, commented the Minister, with only 200 trained pharmacists and 276 registered pharmacies. A newly-passed law, which allows the Ministry to prosecute owners of the unlicensed pharmacies, and impose fines of up to $20,000 and jail sentences of up to 10 years, could help to ease the problem, he noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight